Non-Hodgkin's Lymphoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma
Conditions: Lymphoma; DLBCL; T Cell Lymphoma Intervention: Drug: Selinexor Sponsor: Ruijin Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2023 Category: Research Source Type: clinical trials
